Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging
Molecular Weight:
443.5
CAS Number:
[1800046-95-0]
Formula:
C23H25N9O
Target:
Syk
* VAT and and shipping costs not included. Errors and price changes excepted